Educational guide
Braftide, CAS 2411851-64-2 Peptide for cancer research
Braftide, CAS 2411851-64-2 US$283.60 Excluding tax and shipping fees In stock Description About Braftide, CAS 2411851-64-2 Braftide, CAS 2411851-64-2 (Uniprot: A0A024R178) is an allosteric inhibitor of B-RAF kinase for cancer-targeting research. The Braftide,
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Braftide, CAS 2411851-64-2
US$283.60
Excluding tax and shipping fees
In stock
Description
About Braftide, CAS 2411851-64-2
Braftide, CAS 2411851-64-2 (Uniprot: A0A024R178) is an allosteric inhibitor of B-RAF kinase for cancer-targeting research. The Braftide, CAS 2411851-64-2 peptide, H-TRHVNILLFM-NH2 from JPT is produced under strict quality control and quality management.
Braftide, CAS 2411851-64-2 - Specifications
Peptide sequence: H-TRHVNILLFM-NH2
Amount: 5 mg
Purity: > 90% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Application(s): Cancer research
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
Non-RGD Cancer Peptides from JPT
Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.
Benefits of JPT’s Non-RGD Cancer Peptides
Each peptide quality controlled and guaranteed for identity and purity
CoA and HPLC-MS data available
High batch-to-batch consistency
Synthesis protocols designed to avoid toxic contaminants and side products
Provision of freeze dried aliquots for enhanced stability
Proven track record for applications in clinical studies
References
References for Braftide, CAS 2411851-64-2
ReferencesRead References with Peptides made by JPT
Documentation
Documentation for Braftide, CAS 2411851-64-2
Braftide-CAS 2411851-64-2.pdf
Properties
Properties of Braftide, CAS 2411851-64-2
5 mg
Cancer biomarker research
Cancer peptides
Freeze-dried in plastic vial
Human
Other
>90% (HPLC-MS)
No
Further Information to Braftide, CAS 2411851-64-2
Values
H-TRHVNILLFM-NH2
10mer cancer peptide